Making drug formularies accessible in EHRs can boost medication adherence and improve outcomes

Federal action could close gaps & standardize data, helping patients & clinicians make informed choices

Read more about #PharmaPolicy in this 🆓 full-text #JGIM #Perspective ⬇️:
rdcu.be/eRbtP

European legislators reach agreement on sweeping overhaul to pharma policies European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework aimed at boosting the bloc's competitiveness while strengthening supply chai | ...

EU lawmakers agree on a major rewrite of pharma rules, reshaping data and market exclusivity, speeding reviews and addressing drug shortages. Industry groups welcome faster approvals but warn incentives may fall short on competitiveness.

📰 Read more here:

#EUPharma #LifeSciences #PharmaPolicy

U.S. Medicare Cuts Prices on 15 High-Cost Drugs, Slashing Spending by 36% The U.S. Medicare health program announced on Tuesday that newly negotiated prices for 15 of its most expensive drugs will

U.S. Medicare announces historic price reductions on 15 high-cost drugs, cutting spending by 36% and saving billions for patients and taxpayers.

#MedicareSavings #DrugPriceCuts #HealthcareReform #PrescriptionSavings #PharmaPolicy

UPCOMING EVENT | Pharmaceutical policy at a crossroads 🚧
Hear from leading US & European HTA experts as #LSEHealth launches its new Pharmaceutical Policy Lab. ❗️

10 Dec, 6.30-8pm | Free event
Register now:👉 bit.ly/4qWlBKt

#PharmaPolicy #DrugPricing

Factors influencing the effects of policies and interventions to promote the appropriate use of medicines in high-income countries: A rapid realist review The appropriate use of medicines has long been recognized as a fundamental component of medicine policies. We aimed to extract lessons from published …

Canada is moving towards public single-payer #pharmacare, including a national strategy on the appropriate use of medicines. How can this strategy be successful? Our most recent study with @caden-recad.bsky.social provides answers! #cndpoli #pharmapolicy www.sciencedirect.com/science/arti...

.@US_FDA Commissioner confirmed: The 6 challenges that await @califf001 #PharmaPolicy via @politico

#PharmaPolicy Generic Drug Approvals Continued to Fall in 2021 via @RAPSorg

.@Pfizer and @BioNTech_Group are expected to submit an EUA request to @US_FDA to authorize use of its COVID-19 vaccine in children under 5
via @washingtonpost #PharmaPolicy

$MRNA @moderna_tx vaccine receives full FDA approval via @washingtonpost #PharmaPolicy

Big congrats to #NUSLPatentLaw #PHLaw @NUSL and #PharmaPolicy @CSUEB_HSC @CSUEastBay students graduating this weekend!

Tracking an FDA advisory panel’s meeting on J&J’s Covid-19 vaccine via @statnews #PharmaPolicy

Few Pandemic Treatment Tools on Tap: Covid Therapies Explained via @BLaw @_jacquie_lee #PharmaPolicy